Internal Medicine, Endocrinology, Diabetes, & Metabolism · Colonial Heights, VA
NPI
1912962085
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3660 Boulevard, Suite G
Colonial Heights, VA, 23834
Phone (804) 526-5566
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
1,345 services
Medicare patients, 2024
534
Average age 73
Drug cost, 2024
$3.2M
8,213 prescriptions
Company payments, 2025
$541
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Rekha Nugaram was code 99214 (office e&m - established), 750 times for 475 patients. In total Rekha Nugaram billed 1,345 services in 11 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-02-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 750 | 475 | $80.01 | $60K |
| 95251 Test - Miscellaneous | Office | 230 | 121 | $25.00 | $5,750 |
| 99215 Office E&M - Established | Office | 222 | 159 | $120.36 | $27K |
| 83036 Blood Count | Office | 65 | 58 | $9.52 | $619 |
| 99204 Office E&M - New | Office | 37 | 37 | $98.89 | $3,659 |
| 10005 Other Organ Systems | Office | 18 | 17 | $96.10 | $1,730 |
By year: 2022 $106K for 1,295 services; 2023 $98K for 1,175 services; 2024 $99K for 1,345 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 65 | 58 | $9.52 | $619 |
Medicare prescription drug claims, 2024
In 2024, the drug Rekha Nugaram prescribed most often to Medicare patients was Levothyroxine Sodium, with 548 prescriptions and refills. In total Rekha Nugaram wrote 8,213 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 548 | 1,448 | 147 | $6,567 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 452 | 971 | 133 | $74K |
| Metformin Hcl Er Metformin Hcl | 393 | 988 | 115 | $3,692 |
| Atorvastatin Calcium Generic | 341 | 947 | 109 | $3,005 |
| Metformin Hcl Generic | 333 | 823 | 93 | $2,775 |
| Jardiance Empagliflozin | 317 | 625 | 78 | $354K |
| Trulicity Dulaglutide | 280 | 499 | 77 | $486K |
| Ozempic Semaglutide | 257 | 481 | 68 | $457K |
| Rosuvastatin Calcium Generic | 250 | 679 | 80 | $3,725 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 234 | 560 | 98 | $30K |
| Farxiga Dapagliflozin Propanediol | 195 | 378 | 46 | $207K |
| Humalog Kwikpen U-100 Insulin Lispro | 193 | 397 | 67 | $73K |
| Novolog Flexpen Insulin Aspart | 183 | 336 | 75 | $60K |
| Repaglinide Generic | 148 | 369 | 53 | $5,482 |
| Methimazole Generic | 141 | 332 | 40 | $1,585 |
Brand drugs: 3,624 claims; generic drugs: 3,887 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rekha Nugaram $541 ($541 in general payments such as food, travel and fees) from 13 companies. The largest payer was Lilly USA, LLC with $111.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 6 | $111 |
| Dexcom, Inc. DXCM | 4 | $78.53 |
| Insulet Corporation PODD | 1 | $65.44 |
| CeQur Corporation | 1 | $55.96 |
| Mannkind Corporation MNKD | 1 | $42.5 |
| Abbott Laboratories ABT | 2 | $36.04 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30.25 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $24.04 |
| Ascendis Pharma Endocrinology Inc ASND | 1 | $23.44 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $21.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.